Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
18.73B
Market cap18.73B
Price-Earnings ratio
24.49
Price-Earnings ratio24.49
Dividend yield
0.95%
Dividend yield0.95%
Average volume
2.95M
Average volume2.95M
High today
$100.15
High today$100.15
Low today
$97.87
Low today$97.87
Open price
$99.40
Open price$99.40
Volume
1.62M
Volume1.62M
52 Week high
$108.29
52 Week high$108.29
52 Week low
$79.12
52 Week low$79.12

Stock Snapshot

The current Zimmer Biomet(ZBH) stock price is $98.20, with a market capitalization of 18.73B. The stock trades at a price-to-earnings (P/E) ratio of 24.49 and offers a dividend yield of 0.95%.

During the trading session on 2026-08-17, Zimmer Biomet(ZBH) shares reached a daily high of $100.15 and a low of $97.87. At a current price of $98.20, the stock is +0.3% higher than the low and still -1.9% under the high.

Trading volume for Zimmer Biomet(ZBH) stock has reached 1.62M, versus its average volume of 2.95M.

The stock's 52-week range extends from a low of $79.12 to a high of $108.29.

The stock's 52-week range extends from a low of $79.12 to a high of $108.29.

ZBH News

MarketWatch 5h
Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch

...

Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Simply Wall St 2d
Zimmer Biomet Holdings Could Be 2% Undervalued As Q2 Beat Lifts The Story

Zimmer Biomet Holdings (ZBH) is in focus after second quarter results topped Wall Street expectations, with management pointing to hip market share gains, expan...

Zimmer Biomet Holdings Could Be 2% Undervalued As Q2 Beat Lifts The Story
Simply Wall St 5d
Will Zimmer Biomet’s Upgraded 2026 Guidance and Buyback Shift Zimmer Biomet Holdings’ Narrative

Zimmer Biomet Holdings, Inc. reported past second-quarter 2026 results with sales of US$2,177 million and net income of US$198.3 million, and completed a US$496...

Will Zimmer Biomet’s Upgraded 2026 Guidance and Buyback Shift Zimmer Biomet Holdings’ Narrative

Analyst ratings

69%

of 29 ratings
Buy
31%
Hold
69%
Sell
0%

More ZBH News

Nasdaq 6d
Zimmer Biomet Q2 2026 Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Zimmer Biomet Q2 2026 Earnings Call Transcript

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.